With a properly functioning circle system, which of the following is not a disadvantage of low flow anesthesia?

With a properly functioning circle system, which of the following is not a disadvantage of low flow anesthesia?

• A. Hypercarbia
• B. Hypoxia
• C. Increased compound A exposure
• D. Increased carbon monoxide exposure

Answer: (A)

In low flow anesthesia, the circle system relies more on rebreathing of expired gases, so the main concerns are how well the system handles CO2, how much time the anesthetic agent spends in contact with the CO2 absorber, and what impurities might build up if the absorbent is dry or exhausted. Hypercarbia would only occur if CO2 removal were inadequate. With a properly functioning circle system and an adequate CO2 absorber, CO2 is effectively scrubbed, so elevated CO2 levels are unlikely. That’s why hypercarbia is not considered a disadvantage of low flow when everything is in good working order. The other issues are real considerations. Low fresh gas flow increases the amount of rebreathing, which can lead to higher concentrations of volatile agent and, if the CO2 absorber isn’t functioning well or becomes exhausted, a risk of hypoventilation and hypoxia. Prolonged contact of sevoflurane with a CO2 absorbent at low flows can raise the production of Compound A, a potential nephrotoxic byproduct in animal studies. Desiccated CO2 absorbents can also produce carbon monoxide, especially under certain conditions and with low flow where contact time is longer. So these represent actual disadvantages to monitor and mitigate. Thus, when the circle system is functioning properly, hypercarbia is not a disadvantage of low flow anesthesia, whereas hypoxia risk, increased Compound A exposure, and potential carbon monoxide exposure remain pertinent concerns if the system or absorbent is compromised.

In low flow anesthesia, the circle system relies more on rebreathing of expired gases, so the main concerns are how well the system handles CO2, how much time the anesthetic agent spends in contact with the CO2 absorber, and what impurities might build up if the absorbent is dry or exhausted.

Hypercarbia would only occur if CO2 removal were inadequate. With a properly functioning circle system and an adequate CO2 absorber, CO2 is effectively scrubbed, so elevated CO2 levels are unlikely. That’s why hypercarbia is not considered a disadvantage of low flow when everything is in good working order.

The other issues are real considerations. Low fresh gas flow increases the amount of rebreathing, which can lead to higher concentrations of volatile agent and, if the CO2 absorber isn’t functioning well or becomes exhausted, a risk of hypoventilation and hypoxia. Prolonged contact of sevoflurane with a CO2 absorbent at low flows can raise the production of Compound A, a potential nephrotoxic byproduct in animal studies. Desiccated CO2 absorbents can also produce carbon monoxide, especially under certain conditions and with low flow where contact time is longer. So these represent actual disadvantages to monitor and mitigate.

Thus, when the circle system is functioning properly, hypercarbia is not a disadvantage of low flow anesthesia, whereas hypoxia risk, increased Compound A exposure, and potential carbon monoxide exposure remain pertinent concerns if the system or absorbent is compromised.